Not enough evidence to prove plasma therapy works: Top ICMR scientist on why India changed treatment protocol
3 years, 10 months ago

Not enough evidence to prove plasma therapy works: Top ICMR scientist on why India changed treatment protocol

India Today  

The Centre on Monday revised the clinical guidance for Covid-19 treatment, dropping the off-label use of convalescent plasma from the treatment protocol for adult patients. Dr Samiran Panda, Indian Council of Medical Research scientist who was also a part of the panel that dropped plasma therapy from Covid-19 management guidelines, told India Today that the decision was taken since anecdotal evidence was very weak, and added that it was not helping patients but only resulting in panic. Top ICMR official Cites evidence published in BMJ that plasma doesn’t benefit Anecdotal evidence not good enough Plasma therapy expensive -leading to panic - Leading to burdening of healthcare system https://t.co/7G6rt5c2Cn — Sneha Mordani May 17, 2021 The top ICMR scientist cited ineffectiveness and inappropriate use of plasma therapy in several cases behind the decision, saying it wasn’t found beneficial in reducing the progression to severe disease or death. Plasma therapy dropped from Covid management guidelines A government-appointed task force on Covid-19 removed plasma therapy from the treatment protocol for adult Covid-19 patients. In the revised clinical guidelines for the management of adult Covid-19 patients, the use of convalescent plasma therapy has been removed even as an 'off label treatment.

India Evidence Therapy Guidelines Covid Icmr Scientist Plasma Convalescent Plasma Plasma Therapy Dr Samiran Panda Treatment Protocol  patients  protocol  india  management  panda  treatment  plasma  scientist  guidelines  works  icmr  covid19  therapy  evidence  prove

History of this topic

National Task Force on Covid-19 revises treatment guidelines for adults
2 years ago

National Task Force on Covid-19 revises treatment guidelines for adults

India Today  

Antibiotics should not be used unless there is clinical suspicion of bacterial infection, the National Task Force on Covid-19 said as it revised the clinical guidelines for the management of infection in adults. COVID-19 National Task Force under Ministry of Health and Family Welfare releases revised clinical guidance for the management of adult COVID-19 patients pic.twitter.com/HvaLtE7nTh — ANI March 19, …

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
2 years, 2 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

ICMR identifies biomarkers to diagnose severity, predict recovery of Covid-19
2 years, 2 months ago

ICMR identifies biomarkers to diagnose severity, predict recovery of Covid-19

Hindustan Times  

Mumbai: The National Institute For Research In Reproductive and Child Health of the Indian Council of Medical Research, and Brihanmumbai Municipal Corporation, have identified biomarkers that could help diagnose the severity of Covid-19 through a blood test. In 2021, two separate studies were taken up by the institute on a small cohort of Covid positive blood samples, the results of …

Two years on, India's battle with COVID-19, its variants continue with no end in sight
3 years, 2 months ago

Two years on, India's battle with COVID-19, its variants continue with no end in sight

Firstpost  

Till now, India has reported 4,10,92,522 cases and 4,94,091 fatalities due to COVID-19 and its variants New Delhi: Amid the third wave of the COVID-19 pandemic, India has completed two years since the first coronavirus case was reported in the country and during this time, it has not just battled the virus but also its mutated variants, even as uncertainty …

Two years on, vaccines and following protocols remain most effective weapons against COVID-19
3 years, 2 months ago

Two years on, vaccines and following protocols remain most effective weapons against COVID-19

India TV News  

Highlights India completes two years since the outbreak of Covid was first reported India has witnessed three waves of COVID-19 since Jan 2020 No definitive treatment has emerged as yet As India completed two years since the outbreak of COVID-19, vaccines and following COVID Appropriate Behaviour remain the most effective weapons against the deadly virus. Health Minister Mansukh Mandaviya on …

Curing with Blood: the Rise and Fall of Covid Convalescent Plasma Therapy
3 years, 5 months ago

Curing with Blood: the Rise and Fall of Covid Convalescent Plasma Therapy

News 18  

Early in the pandemic, scientists thought convalescent plasma might be a way to treat COVID-19. But growing evidence, including an international study published this week, shows convalescent plasma does not save lives of people critically ill with COVID-19. year more than 100 clinical trials had been conducted with convalescent plasma in people with COVID-19; about one-third of these studies had …

Use of plasma therapy for Covid may cause adverse events: Study
3 years, 6 months ago

Use of plasma therapy for Covid may cause adverse events: Study

Hindustan Times  

Even with doubtful efficacy, antibody-rich plasma from recovered Covid-19 patients continued to be used for the treatment of those suffering from the infection during the second wave of the pandemic, with people queuing up at plasma banks and looking for donors online. But a recent Canadian study published in the journal Nature has shown that not only did plasma therapy …

Patients unable to produce Covid antibodies supported by new drug
3 years, 8 months ago

Patients unable to produce Covid antibodies supported by new drug

NL Times  

The Erasmus Medical Center has begun using the drug REGEN-Cov to treat patients with Covid-19 who have a reduced ability to produce antibodies themselves. “You are buying time for patients to make their own antibodies”, said Bart Rijnders, an internist and infectious diseases specialist at the hospital. “In patients who will never produce their own antibodies, it helps the other …

Antibody cocktail treatment can help Covid patients recover faster, reduces mortality: BMC
3 years, 8 months ago

Antibody cocktail treatment can help Covid patients recover faster, reduces mortality: BMC

India Today  

The Brihanmumbai Municipal Corporation on Monday said that antibody cocktail treatment can help Covid-19 patients recover faster and reduces mortality rate. The civic body's claim is based on an experiment of antibody cocktail conducted by Mumbai's Seven Hills hospital on 200 patients. ANTIBODY COCKTAIL FOR COVID-19 TREATMENT In order to successfully treat the affected patients and to alleviate the strain …

Monoclonal antibody treatment for COVID-19 could be a game changer
3 years, 9 months ago

Monoclonal antibody treatment for COVID-19 could be a game changer

The Hindu  

Monoclonal antibody treatment is now seen as a relatively effective and safer alternative in treating COVID-19 patients, with doctors stating that, as with any other drug, timing is very important for the administration of the therapy that’s touted as a game changer. “Monoclonal antibody treatment could prove to be a game changer in times to come if used at the …

Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail
3 years, 10 months ago

Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail

India TV News  

Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail Zydus said it is the only Indian company to have developed a neutralizing monoclonal antibody based cocktail for the treatment of COVID-19. Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India to initiate human clinical trials for monoclonal antibodies cocktail for …

Octogenarian COVID patient who received monoclonal antibody therapy, back home: Hospital
3 years, 10 months ago

Octogenarian COVID patient who received monoclonal antibody therapy, back home: Hospital

India TV News  

An 84-year-old Covid positive man who was given monoclonal antibody therapy in Gurgaon, which is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate symptoms, is back to his home, hospital authorities said on Wednesday. Suffering from COVID-19, Singh is the first patient to receive monoclonal antibody therapy at Medanta, Gurgaon, he …

Centralised vaccine procurement, transparency: Lancet panel makes eight recommendations to Centre for COVID-19 management
3 years, 10 months ago

Centralised vaccine procurement, transparency: Lancet panel makes eight recommendations to Centre for COVID-19 management

Firstpost  

The expert panel also recommended ‘minimising the profound suffering and risk’ to health caused by loss of livelihoods by making provisions for cash transfers to workers in informal sectors who lost their jobs With an aim to curtail the loss of life and suffering caused by the second wave of rise in COVID-19 cases across India, a panel of experts …

No proof of Remdesivir's effectiveness in COVID patients; may be dropped soon: Ganga Ram hospital chairperson
3 years, 10 months ago

No proof of Remdesivir's effectiveness in COVID patients; may be dropped soon: Ganga Ram hospital chairperson

India TV News  

No proof of Remdesivir's effectiveness in COVID patients; may be dropped soon: Ganga Ram hospital chairperson This move comes after, the use of convalescent plasma has been dropped from the recommended treatment protocols for COVID -19, according to an advisory from the Indian Council of Medical Research. Ganga Ram hospital Chairperson Dr. DS Rana on Tuesday said that Remdesivir is …

Does India's trial and error approach to fighting mutating coronavirus need course correction?
3 years, 10 months ago

Does India's trial and error approach to fighting mutating coronavirus need course correction?

India Today  

The second wave continues to wreak havoc in India with over 4,500 deaths recorded in a day on Wednesday. The Indian Council of Medical Research decision came within days of a study published in The Lancet that suggested plasma therapy did not improve survival or other pre-specified clinical outcomes in patients. Interestingly, similar data from ICMR's own trials was released …

Delete and control: On ICMR's dropping of plasma therapy
3 years, 10 months ago

Delete and control: On ICMR's dropping of plasma therapy

The Hindu  

The Indian Council of Medical Research has finally dropped its espousal of convalescent plasma therapy as treatment for moderate COVID-19 in its latest guidelines. Last year, the ICMR, in one of the definitive clinical trials in the world, demonstrated that CPT neither saved lives nor improved patient outcomes but was equivocal about it in public. This gave leeway to some …

Top medical experts welcome move to remove plasma therapy from COVID-19 treatment
3 years, 10 months ago

Top medical experts welcome move to remove plasma therapy from COVID-19 treatment

Deccan Chronicle  

New Delhi: Several top medical experts have welcomed the Indian Council of Medical Research 's updated advisory released on Monday dropping the use of convalescent plasma from recommended treatment protocols for COVID-19. Sir Ganga Ram Hospital chairman Dr DS Rana said plasma therapy has failed to change the "course of mortality" and asserted that some scientists are also of the …

Why government has dropped plasma therapy for Covid-19
3 years, 10 months ago

Why government has dropped plasma therapy for Covid-19

India Today  

India has officially removed the use of convalescent plasma, popularly known as the plasma therapy, on Covid-19 patients from its clinical management guidelines for the disease. The previous guidelines allowed “off label” use of plasma therapy on Covid-19 patients during moderate stage within seven days of the onset of symptoms. WHY GOVERNMENT DROPPED PLASMA THERAPY Many a time, the prescription …

Found Ineffective, Plasma Therapy No Longer Recommended For Covid-19 Treatment
3 years, 10 months ago

Found Ineffective, Plasma Therapy No Longer Recommended For Covid-19 Treatment

News 18  

Days after various studies and expert panels suggested that plasma therapy on Covid-19 patients was found ineffective in reducing the progression to severe disease or death, the treatment protocol has been dropped from the clinical management guidelines, sources said. In the letter, which was also marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public health professionals alleged …

Govt removes plasma therapy as treatment for Covid-19 among adults
3 years, 10 months ago

Govt removes plasma therapy as treatment for Covid-19 among adults

India Today  

A government-appointed task force on Covid-19 on Monday removed plasma therapy from the treatment protocol for adult Covid-19 patients. In the revised clinical guidelines for management of adult Covid-19 patients, use of convalescent plasma therapy has been removed even as an 'off label treatment. Until now, India's Covid-19 treatment protocol allowed 'off label' use of convalescent plasma therapy but only …

COVID-19: Plasma therapy not found effective, likely to be dropped from clinical management guidelines
3 years, 10 months ago

COVID-19: Plasma therapy not found effective, likely to be dropped from clinical management guidelines

Firstpost  

The present guidelines allows ‘off label’ use of plasma therapy at the stage of early moderate disease, that is, within seven days of the onset of symptoms New Delhi: Plasma therapy on COVID-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources …

Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19
3 years, 10 months ago

Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19

India Today  

Plasma therapy on Covid-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources said. In the letter, which was also marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public health professionals alleged that the current guidelines on plasma therapy …

ICMR Covid-19 task force to meet on Friday for review on ‘inappropriate use’ of plasma therapy
3 years, 10 months ago

ICMR Covid-19 task force to meet on Friday for review on ‘inappropriate use’ of plasma therapy

Hindustan Times  

The Indian Council of Medical Research’s National task force on Covid-19 is scheduled to meet on Friday to decide on the inappropriate use of convalescent plasma therapy in the treatment of ailing Covid-19 patients, news agency ANI reported quoting ICMR sources. This meeting comes against the backdrop of clinicians and scientists in the country writing to the government's principal scientific …

Stop irrational use of plasma, may develop more virulent strains of Covid, warn experts
3 years, 10 months ago

Stop irrational use of plasma, may develop more virulent strains of Covid, warn experts

India Today  

A group of doctors, public health officials and experts have written to the Centre’s principal scientific advisor along with the AIIMS chief and ICMR chief, raising concerns over the “irrational and non-scientific use of convalescent plasma for Covid-19”. The letter addressed to Principal Scientific Advisor Dr Vijay Raghavan says, “We are writing to you as concerned clinicians, public health professionals …

An Oral History of the COVID-19 Crisis: 'Was shocked when a person demanded Rs 1 lakh for plasma'
3 years, 10 months ago

An Oral History of the COVID-19 Crisis: 'Was shocked when a person demanded Rs 1 lakh for plasma'

Firstpost  

This account is part of Firstpost’s Oral History Project of the COVID-19 Crisis in India. The Oral History Project aims to be an ongoing compendium of individual experiences of the pandemic, with a focus on one significant day in our respondents’ lives during this time. Some said they were preserving blood for sick relatives who might need convalescent plasma therapy …

Fact Check: Old list of blood donors circulated as plasma donors for Covid patients
3 years, 11 months ago

Fact Check: Old list of blood donors circulated as plasma donors for Covid patients

India Today  

As India is battling a renewed surge in Covid-19 cases, several states are witnessing a shortage of plasma from recovered patients. In 2016, a Facebook page named BLOOD DONORS shared the same list as from Andhra Pradesh and Telangana. Even in 2020, after the Covid-19 pandemic broke out in India, the same list had gone viral, claiming to be of …

Donated plasma from Covid-19 survivors is of no benefit for hospital patients, study finds
4 years ago

Donated plasma from Covid-19 survivors is of no benefit for hospital patients, study finds

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Using donated blood plasma from Coronavirus survivors does not help treat …

Convalescent Plasma Strikes Out As COVID-19 Treatment
4 years ago

Convalescent Plasma Strikes Out As COVID-19 Treatment

NPR  

Convalescent Plasma Strikes Out As COVID-19 Treatment Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images More than half a million Americans have received an experimental treatment for COVID-19 called convalescent plasma. Sponsor Message She recalls thinking, "we have this new disease that didn't have any known therapies, and convalescent plasma has been used in new epidemic and …

Scientific disinterest: The Hindu Editorial on Union Health Minister’s presence at Coronil promotion event
4 years, 1 month ago

Scientific disinterest: The Hindu Editorial on Union Health Minister’s presence at Coronil promotion event

The Hindu  

The presence of Union Health Minister Harsh Vardhan at a press conference to promote Coronil, an Ayurvedic pill promoted by Baba Ramdev’s Patanjali Ayurved, is objectionable on more than one count. Dr Vardhan, alongside Cabinet colleague Nitin Gadkari, was at a press conference with Baba Ramdev and other promoters of Patanjali to announce a scientific publication describing the efficacy of …

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR
4 years, 1 month ago

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR

The Hindu  

Indian Council of Medical Research Director General Dr Balram Bhargava has said interim results of the ongoing clinical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil. In the case of the variants from South Africa and Brazil, efforts were on to isolate the mutated …

Study shows Covid-19 evolved during treatment, convalescent plasma therapy patients had UK mutant
4 years, 1 month ago

Study shows Covid-19 evolved during treatment, convalescent plasma therapy patients had UK mutant

India Today  

A recent study has revealed that the dominant variant of the novel coronavirus or Covid-19 that emerged in patients after the convalescent plasma therapy possessed a mutation that is also present in the one first discovered in the UK. ".data reveal strong selection on SARS-CoV-2 during convalescent plasma therapy associated with the emergence of viral variants with evidence of reduced …

Covid research: Convalescent plasma trial paused as results poor
4 years, 2 months ago

Covid research: Convalescent plasma trial paused as results poor

Daily Mail  

Injecting critically ill coronavirus patients with the blood of survivors does not boost their chances of getting better, a major study has found. Scientists running the REMAP-CAP trial have stopped enrolling infected ICU patients after finding 'no evidence' convalescent plasma therapy boosted survival rates. Health Secretary Matt Hancock donated his blood after recovering from coronavirus in March A clinical trial …

Rampant use of convalescent plasma behind Covid mutation?
4 years, 2 months ago

Rampant use of convalescent plasma behind Covid mutation?

New Indian Express  

Cases of mutant Covid jumps to 25 New Delhi: Five new cases of the UK strain of Covid-19 have been detected in India, which takes the total number of such patients to 25. The highly infectious mutant strain, which first surfaced in the UK in September, was found to have reached India two days ago with travellers returning from the …

Complaint About Non-Availability Of Covid19 Vaccine In India Though Available In Other Countries:Allahabad High Court To Discuss With ICMR Today
4 years, 4 months ago

Complaint About Non-Availability Of Covid19 Vaccine In India Though Available In Other Countries:Allahabad High Court To Discuss With ICMR Today

Live Law  

The Allahabad High Court has expressed its inclination to get in touch with the Indian Council of Medical Research to enquire about the status of development/ administration of vaccine for Covid-19 virus. A Division bench comprising of Justices Siddhartha Varma and Ajit Kumar has asked the Central Government to put it in touch with the authority so as to verify …

Coronavirus | ICMR warns against indiscriminate use of convalescent plasma therapy
4 years, 4 months ago

Coronavirus | ICMR warns against indiscriminate use of convalescent plasma therapy

The Hindu  

The Indian Council of Medical Research has warned against indiscriminate use of convalescent plasma therapy for treating COVID-19. On Wednesday, it released report of an open-label phase II multicentre randomised controlled trial conducted across 39 public and private hospitals on the use of CPT in management of cases with moderate infection. The report concluded that the therapy “did not lead …

Indiscriminate Use of Convalescent Plasma Therapy in Covid Patients Not Advisable, Warns ICMR
4 years, 4 months ago

Indiscriminate Use of Convalescent Plasma Therapy in Covid Patients Not Advisable, Warns ICMR

News 18  

The country's apex health research body, ICMR, has issued an advisory statingthat indiscriminate use of convalescent plasma therapy in coronavirus infected patients is not advisable. In an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the Indian Council of Medical Research said that a potential donor for convalescent plasma should have sufficient concentration of antibody …

Indiscriminate Use of Plasma Therapy Not Advisable: ICMR
4 years, 4 months ago

Indiscriminate Use of Plasma Therapy Not Advisable: ICMR

The Quint  

Experts in India have long called out the lack of evidence to support this treatment. Speaking to FIT, Dr Sumit Ray, Senior consultant of Critical Care Medicine, Holy Family Hospital, said, “The theoretical benefit of plasma therapy is in helping boost immunity if not enough is developed in the patient. But, the problem with COVID-19 is not of an inadequate …

Dutch Covid medicine made from blood plasma ready for use
4 years, 4 months ago

Dutch Covid medicine made from blood plasma ready for use

NL Times  

Blood bank Sanquin and plasma producer Sanquin Plasma Products produced 4 thousand doses of Covid-19 antibody treatment made from the blood plasma of recovered patients. The plasma medicine will first go towards preventing coronavirus infections in people with weakened immune systems, such as cancer patients and people who have just undergone an organ transplant. Minister Hugo de Jonge of Public …

Treatment Protocols Being Reassessed 10 Months into Covid-19 Pandemic, Focus on Aspirin as Potential Drug
4 years, 4 months ago

Treatment Protocols Being Reassessed 10 Months into Covid-19 Pandemic, Focus on Aspirin as Potential Drug

News 18  

“From today, aspirin will be investigated in the world’s largest clinical trial of treatments for patients hospitalised with COVID-19. The Randomised Evaluation of COVid-19 therapy trial is taking place in 176 hospital sites across the UK, and has so far recruited over 16,000 patients,” read the RECOVERY Trial’s web information page on Aspirin. This is the newest entrant in the …

The plasma dead end?
4 years, 5 months ago

The plasma dead end?

India Today  

Since ILBS Hospital, in New Delhi, inaugurated its plasma bank in early July, requests have poured in ceaselessly. Many examples of adverse reactions and the inability of plasma treatment to reduce Covid mortality have been recorded in the ICMR’s PLACID trial too. As a result, the ICMR has announced the possibility of removing convalescent plasma therapy as one of the …

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ
4 years, 5 months ago

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ

The Quint  

In India, the treatment first made news in mid-April when a patient in Delhi received experimental plasma therapy and was weaned off from ventilator support. Delhi’s Max Hospital gave a 49-year-old male COVID-19 patient plasma treatment on compassionate grounds. In the experimental treatment, antibodies from the blood of patients who have recovered from coronavirus are given to those battling the …

Recovered COVID-19 patients’ plasma of little use in treatment
4 years, 5 months ago

Recovered COVID-19 patients’ plasma of little use in treatment

Al Jazeera  

Findings of India study, one of first clinical trials to investigate the efficacy of convalescent plasma, are a setback. The findings of one of the first clinical trials to investigate the efficacy of convalescent plasma are a setback for a treatment that United States President Donald Trump touted in August as an “historic breakthrough”. Rigorous study The convalescent plasma technique …

Convalescent plasma therapy DOESN'T cut the risk of dying from Covid-19
4 years, 5 months ago

Convalescent plasma therapy DOESN'T cut the risk of dying from Covid-19

Daily Mail  

A scientific trial has poured cold water on the hope that the blood plasma of recovered Covid-19 patients is an effective treatment for the disease. Health Secretary Matt Hancock, who caught the coronavirus during the UK's first wave at the start of the year, himself donated plasma and encouraged other recovered patients to do the same. He contracted the coronavirus …

Maharashtra caps prices of masks, Calcutta HC modifies Durga Puja order; COVID-19 tally at 76.50 lakh
4 years, 5 months ago

Maharashtra caps prices of masks, Calcutta HC modifies Durga Puja order; COVID-19 tally at 76.50 lakh

Firstpost  

The ministry said that 78 percent of the 54,044 new cases of COVID-19 registered in a span of 24 hours are concentrated in ten states and Union Territories With 54,044 new cases, India’s coronavirus tally on Wednesday rose to 76,51,107, while the toll climbed to 1,15,914 with 717 succumbing to the virus in 24 hours, said the Union health ministry. …

’Plasma therapy has saved lives of many including mine’: Jain on ICMR’s decision
4 years, 5 months ago

’Plasma therapy has saved lives of many including mine’: Jain on ICMR’s decision

Live Mint  

Delhi health minister Satyender Jain on Wednesday said that plasma therapy treatment has saved lives of many from the novel coronavirus in the past months, after the Indian Council of Medical Research on Tuesday said that it considers removing it from Covid-19 national treatment protocol. "Lives of more than 2000 people, including mine, have been saved through plasma therapy, so …

Mumbai local trains to allow women travellers from today; Centre mulls removing plasma therapy as treatment
4 years, 5 months ago

Mumbai local trains to allow women travellers from today; Centre mulls removing plasma therapy as treatment

Firstpost  

Currently only those engaged in frontline duties and falling in the essential staff category of the Maharashtra government are allowed to travel in the local trains run by Central Railway and Western Railway As daily coronavirus cases in India dropped below 50,000 for the first time in nearly three months, Railway minister Piyush Goyal announced that women passengers will be …

ICMR may remove plasma therapy from Covid-19 treatment guidelines
4 years, 5 months ago

ICMR may remove plasma therapy from Covid-19 treatment guidelines

Live Mint  

New Delhi: The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research’s clinical trial showed that the therapy did not significantly benefit patients suffering from the disease, ICMR DG Balram Bhargava said on Tuesday. ICMR, which is the government’s apex bio-medical research agency, had conducted a 464 …

Male, elderly patients with severe COVID-19 may have higher levels of antibodies in their plasma, reveals study
4 years, 5 months ago

Male, elderly patients with severe COVID-19 may have higher levels of antibodies in their plasma, reveals study

Firstpost  

Scientists said that a possible explanation for this could be that due to severe disease, the inflammatory response in the body gets accelerated, recruiting more B-cells to fight the infection. This consequently results in more antibody production In the absence of definitive treatment for COVID-19, doctors are working on repurposing drugs to manage symptoms, reduce disease severity and using plasma …

The Rise & Fall of Plasma Therapy as COVID-19 Treatment in India
4 years, 5 months ago

The Rise & Fall of Plasma Therapy as COVID-19 Treatment in India

The Quint  

On a daily basis, one gets at least two to three messages of desperate family members searching for a plasma donor for their loved ones battling COVID-19. Delhi set up a plasma bank in June to cater to the increasing demand of COVID-19 patients, with several states following the example. In June, the Union Health Ministry, in their clinical guidelines …

Discover Related